Cilostazol 100 MG ( DrugBank: Cilostazol )
1 disease
| 告示番号 | 疾患名（ページ内リンク） | 臨床試験数 |
|---|---|---|
| 46 | 悪性関節リウマチ | 1 |
46. 悪性関節リウマチ
臨床試験数 : 4,356 / 薬物数 : 2,567 - (DrugBank : 415) / 標的遺伝子数 : 192 - 標的パスウェイ数 : 228
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT05671497 (ClinicalTrials.gov) | November 1, 2022 | 14/12/2022 | The Effect of Cilostazol on Rheumatoid Arthritis Patients | Evaluation of the Effect of Cilostazol on the Clinical Outcomes of Rheumatoid Arthritis Patients | Rheumatoid Arthritis | Drug: Cilostazol 100 MG;Drug: conventional synthetic antirheumatic drugs | Ain Shams University | Misr International University;Al-Azhar University | Recruiting | 19 Years | N/A | All | 70 | Phase 2/Phase 3 | Egypt |